Manulife (Manufacturers Life Insurance)’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-76,190
| Closed | -$98.3K | – | 3209 |
|
|
2022
Q1 | $98.3K | Sell |
76,190
-25,225
| -25% | -$23.2K | ﹤0.01% | 2962 |
|
|
2021
Q4 | $129 | Buy |
101,415
+2,522
| +3% | +$4.51K | ﹤0.01% | 3014 |
|
|
2021
Q3 | $216K | Buy |
98,893
+7,178
| +8% | +$19.6K | ﹤0.01% | 2931 |
|
|
2021
Q2 | $344K | Buy |
91,715
+3,558
| +4% | +$12.4K | ﹤0.01% | 2710 |
|
|
2021
Q1 | $287K | Sell |
88,157
-992
| -1% | -$3.56K | ﹤0.01% | 2647 |
|
|
2020
Q4 | $304K | Buy |
89,149
+7,265
| +9% | +$29.9K | ﹤0.01% | 2511 |
|
|
2020
Q3 | $334K | Buy |
81,884
+9,747
| +14% | +$37.1K | ﹤0.01% | 2221 |
|
|
2020
Q2 | $222K | Sell |
72,137
-1,269
| -2% | -$3.7K | ﹤0.01% | 2447 |
|
|
2020
Q1 | $171K | Buy |
73,406
+5,424
| +8% | +$14.8K | ﹤0.01% | 2389 |
|
|
2019
Q4 | $247K | Sell |
67,982
-2,692
| -4% | -$21.8K | ﹤0.01% | 2456 |
|
|
2019
Q3 | $626K | Sell |
70,674
-40
| -0.1% | -$324 | ﹤0.01% | 1891 |
|
|
2019
Q2 | $609K | Buy |
70,714
+4,200
| +6% | +$37.6K | ﹤0.01% | 1926 |
|
|
2019
Q1 | $711K | Buy |
66,514
+4,633
| +7% | +$49.6K | ﹤0.01% | 1882 |
|
|
2018
Q4 | $541K | Sell |
61,881
-4,365
| -7% | -$55.6K | ﹤0.01% | 1917 |
|
|
2018
Q3 | $1.11M | Sell |
66,246
-7,646
| -10% | -$165K | ﹤0.01% | 1731 |
|
|
2018
Q2 | $1.55M | Buy |
73,892
+8,953
| +14% | +$166K | ﹤0.01% | 1605 |
|
|
2018
Q1 | $1.04M | Sell |
64,939
-1,402
| -2% | -$27.8K | ﹤0.01% | 1814 |
|
|
2017
Q4 | $1.26M | Buy |
66,341
+6,396
| +11% | +$116K | ﹤0.01% | 1720 |
|
|
2017
Q3 | $844K | Sell |
59,945
-2,125
| -3% | -$19.2K | ﹤0.01% | 1916 |
|
|
2017
Q2 | $462K | Sell |
62,070
-1,229
| -2% | -$8.03K | ﹤0.01% | 2354 |
|
|
2017
Q1 | $411K | Buy |
63,299
+7,036
| +13% | +$39.3K | ﹤0.01% | 2331 |
|
|
2016
Q4 | $250K | Buy |
56,263
+8,122
| +17% | +$34.1K | ﹤0.01% | 2616 |
|
|
2016
Q3 | $225K | Buy |
48,141
+739
| +2% | +$4.38K | ﹤0.01% | 2690 |
|
|
2016
Q2 | $312K | Buy |
47,402
+1,313
| +3% | +$9.28K | ﹤0.01% | 2353 |
|
|
2016
Q1 | $290K | Buy |
46,089
+448
| +1% | +$2.3K | ﹤0.01% | 2337 |
|
|
2015
Q4 | $275 | Buy |
45,641
+757
| +2% | +$4.33K | ﹤0.01% | 2421 |
|
|
2015
Q3 | $268 | Buy |
44,884
+666
| +2% | +$4.62K | ﹤0.01% | 2420 |
|
|
2015
Q2 | $302 | Sell |
44,218
-1,006
| -2% | -$6.39K | ﹤0.01% | 2502 |
|
|
2015
Q1 | $274 | Buy |
45,224
+1,218
| +3% | +$8.1K | ﹤0.01% | 2501 |
|
|
2014
Q4 | $305 | Buy |
44,006
+311
| +0.7% | +$2.29K | ﹤0.01% | 2340 |
|
|
2014
Q3 | $355 | Buy |
43,695
+1,234
| +3% | +$9.66K | ﹤0.01% | 2225 |
|
|
2014
Q2 | $345K | Sell |
42,461
-6,701
| -14% | -$50.8K | ﹤0.01% | 2318 |
|
|
2014
Q1 | $386 | Sell |
49,162
-149
| -0.3% | -$1.26K | ﹤0.01% | 2262 |
|
|
2013
Q4 | $436 | Buy |
49,311
+1,964
| +4% | +$17.5K | ﹤0.01% | 2154 |
|
|
2013
Q3 | $397 | Sell |
47,347
-1,449
| -3% | -$11.7K | ﹤0.01% | 2143 |
|
|
2013
Q2 | $364K | Buy |
+48,796
| New | +$374K | ﹤0.01% | 2098 |
|
Other funds holding SPPI
ACM
E
Manulife (Manufacturers Life Insurance)'s SPPI Position: Q2 2022 in Review
Manulife (Manufacturers Life Insurance) sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2022, closing a stake of 76,190 shares — an estimated $98.3K sold.
Manulife (Manufacturers Life Insurance) first reported a position in SPPI in Q2 2013 and held it in 36 quarters. The position peaked at $1.55M in Q2 2018. 86 funds tracked by Wall St. Rank hold SPPI as of Q2 2022.
- Manulife (Manufacturers Life Insurance) reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2022 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 76,190 Spectrum Pharmaceuticals Inc shares in Q2 2022, an estimated $98.3K.
- Manulife (Manufacturers Life Insurance) first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 36 quarters.
- Manulife (Manufacturers Life Insurance)'s Spectrum Pharmaceuticals Inc position peaked at $1.55M in Q2 2018.
- 86 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2022.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2022, filed 15 Aug 2022.